1. A composition comprising tricyclodecanedimethylol and at least one polymerizable compound in a weight ratio of from 100:1 to 1:1.
2. The composition according to claim 1, wherein the polymerizable compound is selected from the group consisting of (meth) acrylic acid, esters thereof, O\u2014 and N-vinyl compounds, alkylene oxides, and epichlorohydrin.
3. The composition according to claim 1, wherein tricyclodecanedimethylol and polymerizable compound are present in a weight ratio of from 20:1 to 3:1.
4. The composition according to claim 1, wherein a solvent is additionally present.
5. The composition according to any of claim 1, wherein the solvent is selected from the group consisting of tetrahydrofuran, methanol, butanol, ethylhexanol, and ethylene glycol dimethyl ether.
6. A method of using the composition according to claim 1 comprising using said composition for preparing acrylate and epoxy resins.
7. The composition according to claim 2, wherein tricyclodecanedimethylol and polymerizable compound are present in a weight ratio of from 20:1 to 3:1.
8. The composition according to claim 2, wherein a solvent is additionally present.
9. The composition according to claim 3, wherein a solvent is additionally present.
10. The composition according to claim 2, wherein the solvent is selected from the group consisting of tetrahydrofuran, methanol, butanol, ethylhexanol, and ethylene glycol dimethyl ether.
11. The composition according to claim 3, wherein the solvent is selected from the group consisting of tetrahydrofuran, methanol, butanol, ethylhexanol, and ethylene glycol dimethyl ether.
12. The composition according to claim 4, wherein the solvent is selected from the group consisting of tetrahydrofuran, methanol, butanol, ethylhexanol, and ethylene glycol dimethyl ether.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
What is claimed is:
1. A method for increasing renal blood flow, comprising the steps of:
inserting a catheter into the descending aorta, the catheter having a proximal region, a distal region, and an expandable member mounted on the distal region;
locating the expandable member in the aorta downstream from the takeoff of a renal artery;
expanding the expandable member to at least partially occlude blood flow in the aorta, wherein renal blood flow increases;
measuring a physiologic parameter in the proximal aorta; and
adjusting the expansion of the expandable member based on the measured physiologic parameter.
2. The method of claim 1, wherein a pressure differential exists between the aorta upstream of the balloon and the aorta downstream of the balloon.
3. The method of claim 1, wherein the physiologic parameter measured is blood pressure.
4. The method of claim 1, wherein a lumen of the catheter is adapted for blood flow.
5. The method of claim 1, wherein a lumen of the catheter is adapted to administer a pharmaceutical composition.
6. The method of claim 5, wherein the pharmaceutical composition is selected from the group consisting of vasodilator, cellular protectant, renal protectant, and oxygenated substitute.
7. The method of claim 2, wherein the catheter further comprises a second lumen adapted to receive a medical instrument.
8. The method of claim 1, further comprising the step of advancing a medical instrument through a lumen of the catheter and into an artery that branches from the aorta.
9. The method of claim 8, wherein the medical instrument is selected from the group consisting of a guiding catheter, an infusion catheter, an angioplasty catheter, a laser catheter, an angiography catheter, a therapeutic ultrasound catheter, a hypothermia catheter, a stent catheter, an imaging catheter, a perfusion catheter, an atherectomy catheter, an occlusion catheter, an EP catheter, and an aspiration catheter.
10. The method of claim 1, wherein the step of expanding the expandable member comprises reducing the luminal diameter of the expandable member to reduce blood flow, while an outer diameter of the expandable member remains constant.
11. The method of claim 1, wherein the step of expanding the expandable member includes maintaining the expanded expandable member during systole.
12. The method of claim 1, wherein the expandable member comprises a toroidal balloon, and wherein the step of expanding the expandable member comprises inflating the expandable member.
13. The method of claim 1, wherein the expandable member comprises a balloon, and wherein the step of expanding the expandable member comprises inflating the expandable member.
14. A method for increasing renal blood flow, comprising the steps of:
inserting a catheter into the descending aorta, the catheter having a proximal region, a distal region, and an expandable member mounted on the distal region;
locating the expandable member in the aorta downstream from the takeoff of a renal artery;
expanding the expandable member to at least partially occlude blood flow in the aorta during systole and diastole, wherein renal blood flow increases.
14. The method of claim 14, wherein a pressure differential exists between the aorta upstream of the balloon and the aorta downstream of the balloon.
15. The method of claim 14, wherein a lumen of the catheter is adapted for blood flow.
16. The method of claim 14, wherein the catheter further comprises a second lumen adapted to receive a medical instrument.
17. The method of claim 14, wherein the catheter further comprises a second lumen adapted to administer a pharmaceutical composition.
18. The method of claim 14, wherein the pharmaceutical composition is selected from the group consisting of vasodilator, cellular protectant, renal protectant, and oxygenated substitute.
19. The method of claim 14, further comprising the step of advancing a medical instrument through a lumen of the catheter and into an artery that branches from the aorta.
20. The method of claim 19, wherein the medical instrument is selected from the group consisting of a guiding catheter, an infusion catheter, an angioplasty catheter, a laser catheter, an angiography catheter, a therapeutic ultrasound catheter, a hypothermia catheter, a stent catheter, an imaging catheter, a perfusion catheter, an atherectomy catheter, an occlusion catheter, an EP catheter, and an aspiration catheter.
21. The method of claim 14, wherein the step of expanding the expandable member comprises reducing the luminal diameter of the expandable member to reduce blood flow, while an outer diameter of the expandable member remains constant.
22. The method of claim 14, wherein the step of expanding the expandable member includes maintaining the expanded expandable member during systole.
23. The method of claim 14, wherein the expandable member comprises a toroidal balloon, and wherein the step of expanding the expandable member comprises inflating the expandable member.
24. The method of claim 14, wherein the expandable member comprises a balloon, and wherein the step of expanding the expandable member comprises inflating the expandable member.